CAL-85-1Homo sapiens (Human)Cancer cell line

Also known as: Centre Antoine Lacassagne-85-1, CAL851, CAL85-1, CAL 85-1, Cal-85-1

🤖 AI SummaryBased on 8 publications

Quick Overview

Human cancer cell line with potential applications in cancer research and drug development.

Detailed Summary

CAL-85-1 is a human cancer cell line derived from an unspecified tissue and disease. It is part of a large collection of cancer cell lines used for studying cancer biology, drug sensitivity, and genetic mutations. These cell lines are crucial for understanding the molecular mechanisms of cancer and for developing targeted therapies. Research on CAL-85-1 may contribute to identifying new therapeutic strategies and biomarkers for cancer treatment.
Generated on 6/16/2025

Basic Information

Database IDCVCL_1114
SpeciesHomo sapiens (Human)
Tissue SourceBreast[UBERON:UBERON_0000310]

Donor Information

Age35
Age CategoryAdult
SexFemale
Subtype Featuresbasal TNBC

Disease Information

DiseaseBreast carcinoma
LineageBreast
SubtypeBreast Invasive Ductal Carcinoma
OncoTree CodeIDC

DepMap Information

Source TypeDSMZ
Source IDACH-000857_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Lys132Glu (c.394A>G)Unspecified-PubMed=11914605
MutationSimpleBRCA2p.Ser1461Profs*2 (c.4381delT)Heterozygous-Unknown, Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
12
D13S317
11
D16S539
11,13
D18S51
14
D19S433
15
D21S11
30.2,32.2
D2S1338
20
D3S1358
16
D5S818
11
D7S820
9,10
D8S1179
15
FGA
24
Penta D
9
Penta E
11
TH01
6
TPOX
8,11
vWA
18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Characterization of human cancer cell lines by reverse-phase protein arrays.

Liang H.

Cancer Cell 31:225-239(2017).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

Modeling precision treatment of breast cancer.";

Collisson E.A., van 't Veer L.J., Spellman P.T., Gray J.W.

Genome Biol. 14:R110.1-R110.14(2013).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Effects of tamoxifen on potential doubling time of human breast cancer cell line determined by image cytometry of double fluorescent BrdU and DNA labeling.

Lagrange J.-L., Gioanni J., Caldani C.

Anticancer Res. 14:2025-2032(1994).